期刊文献+

彩色多普勒超声血流阻力指数结合CA 125对卵巢肿瘤的诊断价值 被引量:23

Value of Color Doppler Ultrasound Blood Flow Resistance Index Combined with CA125 in Diagnosis of Ovarian Cancer
下载PDF
导出
摘要 目的探讨彩色多普勒超声血流阻力指数(RI)结合肿瘤标志物CA125判断卵巢肿瘤良恶性的价值。资料与方法 107例卵巢肿瘤患者采用Finkler超声评分系统进行评分,经彩色多普勒超声检查测定RI,同时测定患者血清CA125判断卵巢肿瘤良恶性,并与术后病理进行对照。结果恶性卵巢肿瘤患者Finkler超声评分明显高于良性卵巢肿瘤患者,RI值低于良性卵巢肿瘤患者,CA125明显高于良性卵巢肿瘤患者(P<0.01、P<0.05)。Finkler超声评分、RI结合CA125对卵巢肿瘤良恶性诊断的敏感性及特异性分别为94.59%、89.47%,均高于单一检查方法。结论彩色多普勒超声、RI及肿瘤标志物CA125联合应用对提高卵巢肿瘤良恶性的诊断有一定临床价值。 Purpose To investigate the diagnosis value of combining ultrasound resistance index (RI) and ovarian tumor marker CA125 in diagnosis of benign and malignant ovarian tumors. Materials and Methods 107 patients with ovarian tumor were scored by using the Finkler ultrasound score system. The RI was measured by color Doppler and serum CA125 was detected as well. The results were compared with pathological results. Results The Finkler ultrasound score of malignant tumors was obviously higher than that of benign tumors, while the value of RI was lower than that of benign tumors, CA125 was higher than that of benign tumor group (P 〈0.01, P〈0.05). The diagnostic sensitivity and specificity of Finkler ultrasound score or RI combined with CA125 were higher than that of any single method, which were 94.59% and 89.47%, respectively. Conclusion The combination of Finkler ultrasound score or RI with CA125 can improve the sensitivity and specificity of diagnosing benign and malignant ovarian tumors.
出处 《中国医学影像学杂志》 CSCD 北大核心 2012年第9期692-694,699,共4页 Chinese Journal of Medical Imaging
关键词 卵巢肿瘤 超声检查 多普勒 彩色 抗原 肿瘤相关 碳水化合物 诊断 鉴别 Ovarian neoplasms Ultrasonography, Doppler, color Antigens, tumor-associated, carbohydrate Diagnosis, differential
  • 相关文献

参考文献7

二级参考文献18

  • 1韩素慧,尤凤霞.卵巢肿瘤新生血管形成与病变的关系[J].中国妇幼保健,2003,18(4):24-25. 被引量:5
  • 2李巍,崔恒,冯捷,李艺.卵巢癌诊断的研究进展[J].中华妇产科杂志,2005,40(7):496-498. 被引量:74
  • 3邓凤平,王洁婷,陈颖儿,袁帆,陈小珠,韦瑞红,黄国诚,黎秀英.三维彩色血管能量成像对卵巢肿瘤血管的研究[J].中国超声诊断杂志,2005,6(10):758-760. 被引量:4
  • 4梁雪芳,李燕钰.CA125对卵巢恶性肿瘤诊断价值的评价[J].中华肿瘤防治杂志,2006,13(10):762-762. 被引量:5
  • 5Matin L, Jeff B. Preoperative CA125 levels in patients with hereditary compared to sporadic epithelial ovarian carcinoma [ J ]. Gynecol Oncol, 2002,84 ( 5 ) :413-415.
  • 6McGuire WP. CA125 and early ovarian cancer: does this help the clinician or further muddy the water[J] ? J Clin Oncol, 2005,23 ( 25 ) :5862-5864.
  • 7Fioretti P, Gadducci A, Ferdeghini M, et al. The concomitant determination of different serum tumor markers in epithelial ovarian careimona, Relevance for monitoring the response to chemotherapy and follow up of patients [ J ]. Gynecol Oncol, 1992,44:155-157.
  • 8Yokoyama Y, Higuchi T, Mizunuma H. The potential and problems of screening for ovarian cancer[J]. Eur J Gynaecol Oncol,2005,26 ( 3 ) :241-243.
  • 9Fishman DA, Cohen L, Blank SV, et al. The role of uhrasound evaluation in the detection of early-stage epithelial ovarian cancer[J]. Am J Obstet Gynecol, 2005,192(4):1214-1222.
  • 10Kurjak A,Kupesic S,Anic T,et al.Three-dimensional ultrasound and power Doppler improve the diagnosis of ovarian lesions.Gynecologic Oncology,2000,76:28

共引文献52

同被引文献194

引证文献23

二级引证文献182

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部